Praxis Precision Medicines (PRAX) Return on Equity (2022 - 2025)
Historic Return on Equity for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to 0.78%.
- Praxis Precision Medicines' Return on Equity fell 3700.0% to 0.78% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.78%, marking a year-over-year decrease of 3700.0%. This contributed to the annual value of 0.78% for FY2024, which is 9600.0% up from last year.
- Praxis Precision Medicines' Return on Equity amounted to 0.78% in Q3 2025, which was down 3700.0% from 0.64% recorded in Q2 2025.
- Praxis Precision Medicines' Return on Equity's 5-year high stood at 0.41% during Q2 2024, with a 5-year trough of 2.62% in Q1 2023.
- Moreover, its 4-year median value for Return on Equity was 0.83% (2024), whereas its average is 1.17%.
- In the last 5 years, Praxis Precision Medicines' Return on Equity soared by 17500bps in 2024 and then tumbled by -3700bps in 2025.
- Praxis Precision Medicines' Return on Equity (Quarter) stood at 2.37% in 2022, then skyrocketed by 32bps to 1.62% in 2023, then soared by 70bps to 0.48% in 2024, then plummeted by -62bps to 0.78% in 2025.
- Its Return on Equity stands at 0.78% for Q3 2025, versus 0.64% for Q2 2025 and 0.53% for Q1 2025.